Adheretech, LLC.

Adheretech, LLC. specializes in innovative medication adherence solutions, enhancing patient health outcomes through technology that helps individuals manage their medication routines effectively. Adheretech, LLC. was founded in 2011 and is based in New York, US.

The company focuses on developing products to tackle medication non-adherence. The founders include Grant Mitchell, John Langhauser, and Josh Stein, with Innes Meldrum serving as CEO. Adheretech has successfully completed 4 funding deals, the latest being a Series A round in November 2018, raising USD 1. 75 mn, which matches their total amount raised to date of USD 1.

75 mn. AdhereTech specializes in medication adherence solutions aimed at enhancing patient health outcomes by addressing the challenges of medication non-adherence. The company's core offerings include the Aidia Smart Bottle and the Aidia Smart Cap, which fit over standard prescription bottle caps and provide reminders for patients to take their medication on time. These devices utilize a user-friendly interface to improve medication stability and ensure adherence to prescribed dosing schedules.

The Aidia platform enhances these products by delivering real-time insights and comprehensive reporting tools that equip healthcare providers with actionable data, facilitating timely interventions. AdhereTech's solutions primarily serve patients managing chronic diseases, healthcare providers, and pharmaceutical companies, operating in the United States and select regions in Europe. AdhereTech generates revenue through a business-to-business model, collaborating with healthcare providers and pharmaceutical companies to integrate their adherence solutions into existing patient care workflows. The Aidia Smart Bottle and Smart Cap are provided through subscription plans or partnerships designed to enhance patient engagement and medication adherence.

Clients benefit from the data analytics and reporting capabilities of the Aidia platform, which facilitate better patient management and support increased prescription rates. The pricing structure is aligned with the specific needs of healthcare clients to drive patient compliance and retention over time. In November 2018, Adheretech, LLC. raised funding from Argentum, which will support their initiatives for future growth, including the development of new products and expansion into new markets.

While specific upcoming product launches have not been disclosed, the company aims to broaden its geographic reach in the healthcare sector, specifically targeting regions in Europe, by 2025.